Cristina Andreani

8PUBLICATIONS
56CO-AUTHORS
Molecular targetsTumour immunologyMetabolic medicinePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 06, 2025
Thioredoxin Reductase 1 inhibition triggers ferroptosis in KRAS-independent lung cancers.

Cristina Andreani, Caterina Bartolacci, Margherita Melegari

|Sep 28, 2024
Anticancer Activity of Imidazolyl Gold(I/III) Compounds in Non-Small Cell Lung Cancer Cell Lines.

Rossana Galassi, Nicola Sargentoni, Sofia Renzi

|Aug 01, 2024
Coordinated Targeting of S6K1/2 and AXL Disrupts Pyrimidine Biosynthesis in PTEN-Deficient Glioblastoma.

Catherine A Behrmann, Kelli N Ennis, Pranjal Sarma

|Aug 26, 2022
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer.

Junbiao Wang, Alessia Lamolinara, Laura Conti

|Aug 08, 2022
Author Correction: Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer.

Caterina Bartolacci, Cristina Andreani, Gonçalo Vale

|Jul 26, 2022
Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer.

Caterina Bartolacci, Cristina Andreani, Gonçalo Vale

Pageof 2